Skip to main content
. 2022 Apr 5;206(1):44–55. doi: 10.1164/rccm.202106-1439OC

Table 2.

Relationship of Air Pollution Exposure with Lung Function and Chronic Obstructive Pulmonary Disease

    Lung Function COPD
Exposure n FEV1 (ml)
β (95% CI)
FEV1/FVC (%)
β (95% CI)
Cases/Noncases OR (95% CI)
PM2.5 (continuous)
(per IQR increase = 2.4 μg/m3)
1,451 101.7 (−166.2 to −37.2) −0.6 (−1.7 to 0.5) 691/760 1.17 (0.89 to 1.54)
PM2.5 (categorical), μg/m3          
 Low (2.6 to 5.6) 404 Reference Reference 199/205 Reference
 Medium (5.7 to 8.7) 768 108.0 (−188.8 to −27.3) −1.1 (−2.4 to 0.3) 361/407 1.13 (0.80 to 1.59)
 High (8.8 to 11.9) 279 261.9 (−391.7 to −132.1) 2.3 (−4.5 to −0.1) 131/148 1.57 (0.90 to 2.73)
NO2 (per IQR increase = 9.2 ppb) 1,452 115.0 (−196.5 to −33.4) −1.1 (−2.5 to 0.3) 691/761 1.19 (0.84 to 1.68)
NO2 (categorical), ppb          
 Low (0.5 to 11.3) 507 Reference Reference 227/280 Reference
 Medium (11.4 to 22.1) 881 −87.1 (−190.9 to 16.8) −0.8 (−2.5 to 1.0) 431/450 1.30 (0.84 to 2.03)
 High (22.2 to 33) 64 268.84 (−434.21 to −103.47) −2.6 (−5.4 to 0.2) 33/31 1.58 (0.78 to 3.18)

Definition of abbreviations: CI = confidence interval; COPD = chronic obstructive pulmonary disease; IQR = interquartile range; NO2 = nitrogen dioxide; OR = odds ratio; PM2.5 = fine particulate matter.

All models are adjusted for age, sex, body mass index, educational level (high school or lower vs. postsecondary education), tobacco status (never smoker, former smoker, or current smoker), pack-years smoking, environmental tobacco smoke at home, biomass fuel exposure, respiratory medication intake, and Canadian Cohort Obstructive Lung Disease study site. Statistically significant results are shown in bold.